BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18662694)

  • 21. Three-color labeling method for flow cytometric measurement of cytogenetic damage in rodent and human blood.
    Dertinger SD; Camphausen K; Macgregor JT; Bishop ME; Torous DK; Avlasevich S; Cairns S; Tometsko CR; Menard C; Muanza T; Chen Y; Miller RK; Cederbrant K; Sandelin K; Pontén I; Bolcsfoldi G
    Environ Mol Mutagen; 2004; 44(5):427-35. PubMed ID: 15517570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of circulating endothelial progenitor cells: a methodological comparison of six flow cytometric approaches.
    Van Craenenbroeck EM; Conraads VM; Van Bockstaele DR; Haine SE; Vermeulen K; Van Tendeloo VF; Vrints CJ; Hoymans VY
    J Immunol Methods; 2008 Mar; 332(1-2):31-40. PubMed ID: 18255093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated levels of circulating endothelial progenitor cells in head and neck cancer patients.
    Brunner M; Thurnher D; Heiduschka G; Grasl MCh; Brostjan C; Erovic BM
    J Surg Oncol; 2008 Dec; 98(7):545-50. PubMed ID: 18792958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flow cytometric measurement of circulating endothelial cells: the effect of age and peripheral arterial disease on baseline levels of mature and progenitor populations.
    Shaffer RG; Greene S; Arshi A; Supple G; Bantly A; Moore JS; Mohler ER
    Cytometry B Clin Cytom; 2006 Mar; 70(2):56-62. PubMed ID: 16456866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating endothelial cells: a new candidate biomarker of irreversible pulmonary hypertension secondary to congenital heart disease.
    Smadja DM; Gaussem P; Mauge L; Israël-Biet D; Dignat-George F; Peyrard S; Agnoletti G; Vouhé PR; Bonnet D; Lévy M
    Circulation; 2009 Jan; 119(3):374-81. PubMed ID: 19139384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A six-color flow cytometric assay for the analysis of peripheral blood dendritic cells.
    Giannelli S; Taddeo A; Presicce P; Villa ML; Della Bella S
    Cytometry B Clin Cytom; 2008 Nov; 74(6):349-55. PubMed ID: 18561201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating endothelial cells as a prognostic marker in thrombotic microangiopathy.
    Erdbruegger U; Woywodt A; Kirsch T; Haller H; Haubitz M
    Am J Kidney Dis; 2006 Oct; 48(4):564-70. PubMed ID: 16997052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-reproducible flow cytometric endothelial progenitor cell determination in human peripheral blood as CD34+/CD144+/CD3- lymphocyte sub-population.
    Redondo S; Hristov M; Gordillo-Moscoso AA; Ruiz E; Weber C; Tejerina T
    J Immunol Methods; 2008 Jun; 335(1-2):21-7. PubMed ID: 18402976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A flow cytometric protocol for enumeration of endothelial progenitor cells and monocyte subsets in human blood.
    Hristov M; Schmitz S; Nauwelaers F; Weber C
    J Immunol Methods; 2012 Jul; 381(1-2):9-13. PubMed ID: 22537800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of circulating urothelial cancer cells in the blood using the CellSearch System.
    Naoe M; Ogawa Y; Morita J; Omori K; Takeshita K; Shichijyo T; Okumura T; Igarashi A; Yanaihara A; Iwamoto S; Fukagai T; Miyazaki A; Yoshida H
    Cancer; 2007 Apr; 109(7):1439-45. PubMed ID: 17326057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flow cytometric assay for quantitative and qualitative evaluation of adhesive interactions of tumor cells with endothelial cells.
    Paprocka M; Duś D; Mitterrand M; Lamerant-Fayel N; Kieda C
    Microvasc Res; 2008 Aug; 76(2):134-8. PubMed ID: 18675997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of circulating VEGFR2+ bone marrow-derived progenitor cells in patients with advanced cancer.
    Massard C; Borget I; Le Deley MC; Taylor M; Gomez-Roca C; Soria JC; Farace F
    Eur J Cancer; 2012 Jun; 48(9):1354-62. PubMed ID: 22370181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of a standardized method for enumerating circulating endothelial cells and progenitors: flow cytometry and molecular and ultrastructural analyses.
    Mancuso P; Antoniotti P; Quarna J; Calleri A; Rabascio C; Tacchetti C; Braidotti P; Wu HK; Zurita AJ; Saronni L; Cheng JB; Shalinsky DR; Heymach JV; Bertolini F
    Clin Cancer Res; 2009 Jan; 15(1):267-73. PubMed ID: 19118054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry.
    Khan SS; Solomon MA; McCoy JP
    Cytometry B Clin Cytom; 2005 Mar; 64(1):1-8. PubMed ID: 15668988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The multifaceted circulating endothelial cell in cancer: towards marker and target identification.
    Bertolini F; Shaked Y; Mancuso P; Kerbel RS
    Nat Rev Cancer; 2006 Nov; 6(11):835-45. PubMed ID: 17036040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of CD45-/CD31+/CD105+ circulating cells in the peripheral blood of patients with gynecologic malignancies.
    Yu HK; Lee HJ; Choi HN; Ahn JH; Choi JY; Song HS; Lee KH; Yoon Y; Yi LS; Kim JS; Kim SJ; Kim TJ
    Clin Cancer Res; 2013 Oct; 19(19):5340-50. PubMed ID: 23922300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flow cytometric quantification of tumour endothelial cells; an objective alternative for microvessel density assessment.
    Baeten CI; Wagstaff J; Verhoeven IC; Hillen HF; Griffioen AW
    Br J Cancer; 2002 Jul; 87(3):344-7. PubMed ID: 12177806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A six-colour flow cytometric method for simultaneous detection of cell phenotype and apoptosis of circulating endothelial cells.
    Mariucci S; Rovati B; Chatzileontiadou S; Bencardino K; Manzoni M; Delfanti S; Danova M
    Scand J Clin Lab Invest; 2009; 69(3):433-8. PubMed ID: 19140086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enrichment of Circulating Endothelial Cells by CD34 Microbeads Followed by Enumeration Using Flow Cytometry.
    Burylo AM; de Weger VA; Stuurman FE; Beijnen JH; Schellens JHM
    Thromb Haemost; 2017 Dec; 117(12):2356-2368. PubMed ID: 29212123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential CD146 expression on circulating versus tissue endothelial cells in rectal cancer patients: implications for circulating endothelial and progenitor cells as biomarkers for antiangiogenic therapy.
    Duda DG; Cohen KS; di Tomaso E; Au P; Klein RJ; Scadden DT; Willett CG; Jain RK
    J Clin Oncol; 2006 Mar; 24(9):1449-53. PubMed ID: 16549839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.